United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
541.51
+1.48 (0.27%)
Oct 15, 2026, 4:00 PM EDT - Market closed
United Therapeutics Market Cap
United Therapeutics has a market cap or net worth of $23.23 billion as of October 15, 2026. It is the 1,051st most valuable company in the world and the 431st biggest in the United States. Its market cap has increased by 18.43% in one year.
Market Cap
23.23B
Enterprise Value
19.42B
1-Year Change
18.43%
Global Rank
Country Rank
#431 United States
Category
ChartMarket Cap Chart
Since June 17, 1999, United Therapeutics's market cap has increased from $185.60M to $23.23B, an increase of 12,413.87%. That is a compound annual growth rate of 19.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 23.23B | 10.71% |
| Dec 31, 2025 | 20.98B | 33.18% |
| Dec 31, 2024 | 15.75B | 52.44% |
| Dec 29, 2023 | 10.33B | -18.47% |
| Dec 30, 2022 | 12.67B | 30.24% |
| Dec 31, 2021 | 9.73B | 44.26% |
| Dec 31, 2020 | 6.75B | 74.53% |
| Dec 31, 2019 | 3.87B | -18.57% |
| Dec 31, 2018 | 4.75B | -25.75% |
| Dec 29, 2017 | 6.39B | 5.09% |
| Dec 30, 2016 | 6.08B | -14.87% |
| Dec 31, 2015 | 7.15B | 16.16% |
| Dec 31, 2014 | 6.15B | 8.32% |
| Dec 31, 2013 | 5.68B | 109.29% |
| Dec 31, 2012 | 2.71B | -1.54% |
| Dec 30, 2011 | 2.76B | -23.40% |
| Dec 31, 2010 | 3.60B | 26.94% |
| Dec 31, 2009 | 2.83B | 95.09% |
| Dec 31, 2008 | 1.45B | -30.01% |
| Dec 31, 2007 | 2.08B | 64.45% |
| Dec 29, 2006 | 1.26B | -20.99% |
| Dec 30, 2005 | 1.60B | 58.72% |
| Dec 31, 2004 | 1.01B | 105.98% |
| Dec 31, 2003 | 488.70M | 39.91% |
| Dec 31, 2002 | 349.30M | 65.94% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 59.20B |
| Teva Pharmaceutical Industries | 47.45B |
| Haleon | 43.01B |
| Zoetis | 31.11B |
| Viatris | 20.03B |
| Neurocrine Biosciences | 13.82B |
| Elanco Animal Health | 11.27B |
| Dr. Reddy's Laboratories | 10.63B |